{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:50:11Z","timestamp":1791377411365,"version":"4.3.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular-kidney-metabolic (CKM) syndrome represents a progressive pathophysiological continuum. While clonal hematopoiesis of indeterminate potential (CHIP) is known to increase the risk of CKM disease onset and adverse prognoses, its overall and stage-specific impacts on cardiovascular mortality within the CKM framework, alongside the circulating proteomic mechanisms mediating this excess risk, remain largely unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants from the UK Biobank with available CHIP data across the CKM syndrome continuum were included. The primary outcome was cardiovascular mortality. Kaplan-Meier curves and multivariable Cox proportional hazards models were utilized to evaluate the incremental risk conferred by CHIP. Sensitivity and subgroup analyses were conducted to ascertain result robustness. Within UKB Pharma Proteomics Project (UKB-PPP), circulating proteins jointly associated with CHIP and cardiovascular mortality were identified, followed by functional enrichment and mediation analyses to elucidate the underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 16.5 years, 6,515 cardiovascular deaths were recorded among 288,384 participants across CKM stages 1\u20134. Across all varying CKM stages, individuals harboring Large CHIP exhibited a significantly higher risk of cardiovascular mortality compared to the non-CHIP group (all log-rank P &amp;lt; 0.05). Following multivariable adjustment, Large CHIP emerged as an independent risk factor for cardiovascular mortality (hazard ratio, 1.24; 95% confidence interval, 1.09\u20131.40), with subgroup analyses confirming consistent effects regardless of CKM stage or established cardiometabolic and renal diseases. Proteomic profiling, corroborated by UKB-PPP, revealed that the mechanisms driving this excess risk predominantly involve immune-inflammatory dysregulation and tissue structural remodeling. This pathway was highlighted by critical downstream mediators, including the structural component DSC2 (mediating 34.3% of the risk) and key immune-regulatory receptors such as VSIG4 (33.1%) and CD300C (29.2%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CHIP is an independent risk factor for cardiovascular mortality across all stages of CKM syndrome. Mechanistically, CHIP exacerbates this adverse outcome primarily by driving systemic inflammation, immune dysregulation, and aberrant tissue remodeling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1910361","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:50:25Z","timestamp":1791373825000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of clonal hematopoiesis of indeterminate potential with cardiovascular mortality in cardiovascular-kidney-metabolic syndrome: a large prospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Zehao","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsheng","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiliang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxuan","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"National Clinical Research Center For Cardiovascular Disease","place":["Beijing, China"]},{"name":"Beijing Institute of Heart Lung and Blood Vessel Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: A presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020","volume":"331","author":"Aggarwal","year":"2024","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.067626","article-title":"Development and validation of the American Heart Association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/cir.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: A scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01148-9","article-title":"Clonal haematopoiesis in cardiovascular disease: Prognostic role and novel therapeutic target","volume":"22","author":"Schuermans","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.05.045","article-title":"Clonal hematopoiesis of indeterminate potential reshapes age-related CVD: JACC review topic of the week","volume":"74","author":"Khetarpal","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1681\/asn.0000000680","article-title":"Clonal hematopoiesis of indeterminate potential and progression of CKD","volume":"36","author":"Vlasschaert","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-0805","article-title":"Clonal hematopoiesis of indeterminate potential (CHIP) and incident type 2 diabetes risk","volume":"46","author":"Tobias","year":"2023","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.jacc.2023.03.401","article-title":"Clonal hematopoiesis of indeterminate potential predicts adverse outcomes in patients with atherosclerotic cardiovascular disease","volume":"81","author":"Gumuser","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.ad","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018825","article-title":"A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets","volume":"141","author":"Vlasschaert","year":"2023","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.119.044362","article-title":"Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis","volume":"141","author":"Bick","year":"2020","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcaf010","article-title":"Educational inequalities in cardiovascular diseases and their mediating factors across different generations: A prospective cohort study","volume":"11","author":"Wang","year":"2025","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"B17","doi-asserted-by":"publisher","first-page":"102810","DOI":"10.2139\/ssrn.4807171","article-title":"Association between alcohol consumption and incidence of dementia in current drinkers: Linear and non-linear mendelian randomization analysis","volume":"76","author":"Zheng","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwad179","article-title":"Relation of Life\u2019s Essential 8 to the genetic predisposition for cardiovascular outcomes and all-cause mortality: Results from a national prospective cohort","volume":"30","author":"Zhang","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/75556","article-title":"Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/eurheartj\/ehad670","article-title":"Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias","volume":"45","author":"Schuermans","year":"2024","journal-title":"Eur Heart J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2025.4603","article-title":"Clonal hematopoiesis and incident heart failure","volume":"11","author":"Flynn","year":"2026","journal-title":"JAMA Cardiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2026.121690","article-title":"Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease","volume":"47","author":"von Scheidt","year":"2026","journal-title":"Eur Heart J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-026-04711-4","article-title":"Routine inflammatory indices modify clonal hematopoiesis-related prognostic risk in patients undergoing percutaneous coronary intervention: A real-world cohort study","volume":"24","author":"Shen","year":"2026","journal-title":"BMC Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01382-3","article-title":"Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease","volume":"36","author":"Dawoud","year":"2022","journal-title":"Leukemia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.08.014","article-title":"Clonal hematopoiesis of indeterminate potential and kidney function decline in the general population","volume":"81","author":"Kestenbaum","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12933-025-02626-7","article-title":"Clonal hematopoiesis of indeterminate potential, health indicators, and risk of cardiovascular diseases among patients with diabetes: A prospective cohort study","volume":"24","author":"Sun","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.124.017915","article-title":"Impact of carrying DNMT3A or TET2 mutations on plaque characteristics and prognosis in patients with STEMI based on OCT","volume":"18","author":"Sun","year":"2025","journal-title":"Circ Cardiovasc Imaging"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.124.072909","article-title":"TET2-mutant clonal hematopoiesis promotes heart failure with preserved ejection fraction","volume":"151","author":"Pandey","year":"2025","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.064170","article-title":"Clonal hematopoiesis in clinical and experimental heart failure with preserved ejection fraction","volume":"148","author":"Cochran","year":"2023","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41467-023-43003-w","article-title":"DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts","volume":"15","author":"Shumliakivska","year":"2024","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.120.317104","article-title":"Clonal hematopoiesis-driver DNMT3A mutations alter immune cells in heart failure","volume":"128","author":"Abplanalp","year":"2021","journal-title":"Circ Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jamacardio.2024.0459","article-title":"Atrial fibrillation and clonal hematopoiesis in TET2 and ASXL1","volume":"9","author":"Saadatagah","year":"2024","journal-title":"JAMA Cardiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.065597","article-title":"Clonal hematopoiesis of indeterminate potential with loss of Tet2 enhances risk for atrial fibrillation through Nlrp3 inflammasome activation","volume":"149","author":"Lin","year":"2024","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41467-017-01327-4","article-title":"VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.diff.2020.03.003","article-title":"The multiple roles of Thy-1 in cell differentiation and regeneration","volume":"113","author":"Yang","year":"2020","journal-title":"Differentiation"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/srep23942","article-title":"CD300c is uniquely expressed on CD56bright natural killer cells and differs from CD300a upon ligand recognition","volume":"6","author":"Dimitrova","year":"2016","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1159\/000350523","article-title":"CD300c is an activating receptor expressed on human monocytes","volume":"5","author":"Simhadri","year":"2013","journal-title":"J Innate Immun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2011.173","article-title":"Pathophysiology of arrhythmogenic cardiomyopathy","volume":"9","author":"Basso","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.124.072340","article-title":"Modified mRNA treatment restores cardiac function in desmocollin-2-deficient mouse models of arrhythmogenic right ventricular cardiomyopathy","volume":"151","author":"Zou","year":"2025","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022222","article-title":"Causes and consequences of clonal hematopoiesis","volume":"142","author":"Weeks","year":"2023","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001404","article-title":"Clonal hematopoiesis and its cardiovascular implications: A scientific statement from the American Heart Association","volume":"153","author":"Rhee","year":"2026","journal-title":"Circulation"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41562-023-01579-9","article-title":"Participation bias in the UK Biobank distorts genetic associations and downstream analyses","volume":"7","author":"Schoeler","year":"2023","journal-title":"Nat Hum Behav"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1910361\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:50:27Z","timestamp":1791373827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1910361\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":47,"alternative-id":["10.3389\/fendo.2026.1910361"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1910361","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1910361"}}